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Chapter 1. Environmental Enteric 
Dysfunction (EED) Background 
1.1 EED History and Overview 
For many years it has been known that the digestive system, and in particular the small 
bowel, of people who reside in poor regions do not function well. The first English language 
description of this disorder was written by William Hillary in the mid-1700s. His case series of 
malabsorption in European expatriates in Barbados [2] (reviewed by Booth [3]) also reported 
glossitis (most likely caused by concomitant folate deficiency) and diarrhea. Over a century 
later, Patrick Manson re-described this disorder, again focusing on expatriates in the Dutch 
West Indies, and used the term tropical “Sprouw,” from a Dutch word describing what was 
almost certainly celiac disease (gluten-sensitive enteropathy) in Europe [4]. The onset of this 
malady in previously healthy Europeans residing in the tropics, and reports of epidemic 
malabsorption in Allied troops in Southern Asia during the Second World War [5, 6], gave rise to 
the concept of gut lesions caused by “environmental” factors. Therefore, this enteropathy was 
modeled as an acquired, likely infectious, problem [7]. This acquired/environmental concept was 
reinforced by secular variances in the incidence of tropical malabsorption syndromes, 
alternately referred to as tropical enteropathy (TE), in areas previously endemic for this disorder 
[8, 9]. 
The early descriptions of tropical enteropathy did not define the true extent of the 
problem. Most notably, these initial reports focused on adults. The realization that children were 
affected by what was probably the same disorder was delayed. Second, while various causes of 
this intestinal dysfunction have been postulated, the definitive cause or causes remain(s) 
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elusive. Indeed, interest and investigation into the problem itself waxes and wanes with 
discoveries of new enteric pathogens. This has implications for our systematic review of the 
problem. For example, giardiasis would be a lead candidate as a cause of tropical enteropathy 
in view of the chronicity of the illnesses it can cause, and the ability of Giardia to injure the 
mucosa of the small bowel. However, Giardia lamblia was not widely accepted as a human 
pathogen until the 1970s. Hence, prior investigations would have discounted this agent as being 
a cause of enteropathy. Third, there have been regional differences in the reported incidence of 
tropical enteropathy. Early communications suggested that individuals in Africa were seemingly 
less affected than were individuals in other areas, and that many cases of adult malabsorption 
were attributed to biliary and pancreatic disorders [10]. However, more recent reports suggest 
that Africans are, indeed, susceptible to tropical enteropathy [11-15]. Also, diagnosis in early 
studies was made by varying methodologies, including those based on response to empiric 
treatments (antibiotics, antiparasitics, micronutrients) and repatriation to countries in which 
tropical enteropathy is not endemic; it is often unclear from which intervention(s) responders 
benefitted. Finally, enteric dysfunction in resource-poor settings has often eluded, and continues 
to elude, useful definition. Instead, we are forced to rely on histopathologic findings from the 
small bowel, and these findings are variably specific. These abnormalities include villous 
blunting, increased crypt:villous ratios, and presence of intraepithelial lymphocytes (IEL). 
However, the reliance on biopsies skews disease detection and data acquisition towards adults 
who more frequently undergo invasive testing [16]. These definitional issues continue to hinder 
advancement in the field, and to impose challenges in identifying useful biomarkers. 
The nomenclature used to describe the entity of interest has shifted in response to 
ongoing efforts to better understand and describe the disease. As early as 1984, the term 
“environmental enteropathy” was used synonymously with “tropical enteropathy” [17], although 
not commonly until 2004 [18]. Most recently, "environmental enteric dysfunction" (EED) has 
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been suggested as nomenclature for the entity of interest [16]. We adopt this term in this book 
as it provides specificity with regards to the origin of intestinal dysfunction (i.e., environmental 
opposed to genetic or other factors) and focuses on functional alterations of consequence [19]. 
The term EED refers to functional shortcomings of the gut with and/or without histological 
correlates, and obviates the need to rely on the histology inferred by the term “enteropathy"1. 
We acknowledge that EED might differ in disease burden, etiology, and effects in children and 
adults in different regions. However, independent of case definition or underlying criteria, 
suboptimal intestinal function in children in resource-poor environments is common, and it is 
important to determine its true incidence, spectrum of host injury, mechanisms of 
pathophysiology, diagnostic ascertainment, clinical consequences, and mitigation via 
interventions whether prevention or treatment. Therefore, it is now time to measure the extent of 
this dysfunction and its consequences. To do so, we need to consider the technology that will 
be required to investigate the problem. 
1.2 An Old Problem Requiring New Knowledge 
There is a compelling need for research on enteric dysfunction in children in resource-
poor environments, but scientific advancement in the field has been, in fact, quite modest. The 
Web of Science (formerly ISI Web of Knowledge) demonstrates a paucity of publications related 
to EED (Figure 1).  
                                                     
1 Strictly speaking, the “-pathy” suffix is from the Greek word for disease or suffering, but in many 
connotations refers to histopathologically defined disorders. 
3
Figure 1. List of plausibly relevant literature from 1980 to 2010. 
A search of Thomson Reuters Web of Science™ ALL Databases Collection1 on 27 August 
2014, spanning 1980-2010 and using any of the following search terms: "tropical enteropathy", 
"environmental enteropathy", "tropical sprue", "environmental enteric dysfunction", "tropical 
malabsorption syndrome", or "tropical malabsorption." Topic was used for the query, with the 
phrase enclosed in quotation marks. Search filters for language or document type were not 
applied. 
 
The lack of progress on EED contrasts with recent dramatic advances in mortality 
reduction caused by acute enteric infections. The annual number of deaths attributed to 
diarrhea among children under five years of age fell from an estimated 4.6 million in 1980 [20] to 
about 700,000 in 2011 [21]. Most of the mortality reduction in the latter two decades of the past 
century was likely a result of refinements in, and/or increased use of, oral rehydration 
                                                     
1 Searches were conducted using the Thomson Reuters Web of Science™ ALL Databases Collection and 
reflect only the data as indexed by the database. Publication data may be incomplete. The Thomson 
Reuters Web of Science™ ALL Databases Collection consisted of Inspec® (1898-present), MEDLINE® 
(1950-present), SciELO Citation Index (1997-present), Science Citation Index Expanded (1970-present), 
Social Sciences Citation Index (1970-present) and Art & Humanities Citation Index (1975-present). 
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therapy(ORT) [22, 23]. Globally, current ORT coverage rates are moderate and have stabilized 
over the past decade [24]; more recent reductions in diarrhea-related mortality likely stem from 
general improvements in socioeconomic development, nutrition, and water/sanitation 
infrastructure [25]. Coverage rates for access to improved water sources, particularly in urban 
settings, are on track to meet international development goals [26]. However, access to 
adequate quantities of water, water of sufficient quality for drinking, and improved sanitation 
facilities are limited and only slowly improving [26-28]; the same lack of progress applies to 
hand hygiene prevalences [29]. Improved water sources, sanitation, and hygiene can avert 58% 
of childhood diarrhea-related deaths in low- and middle-income countries [27]. A 34% reduction 
in risk of diarrheal disease has been demonstrated with interventions to improve water quality, 
and a 28% reduction in diarrheal disease has been observed with improvements in sanitation, 
particularly sewer interventions [30]. Promotion of hand hygiene with soap is estimated to 
contribute to a 23% reduction in diarrheal disease risk [29]. 
Treatment with zinc can reduce the duration and severity of acute episodes of diarrhea 
and reduce the risk of future episodes [31-33]. Since 2004, zinc has been a recommended 
therapeutic for children suffering from diarrheal episodes in resource-limited settings. Safe and 
effective rotavirus vaccines are now available and recommended for widespread use [34-36]. 
Coverage rates for these relatively “new” interventions are low, but their implementation is 
accelerating. Major advances might also be on the horizon in the form of effective cholera, 
typhoid, Shigella, and enterotoxigenic Escherichia coli (ETEC) vaccines [37-39]. 
Despite reductions in mortality risk associated with acute diarrhea, enteric infections 
remain prevalent. Over 1.7 billion episodes of diarrhea occur among children under five years of 
age each year [21] and incidence rates have not changed markedly in the past several decades 
[40]. Repeated episodes of infection in the developing gut are probably deleterious [41]. 
Expanded implementation of prevention and treatment measures could further diminish diarrhea 
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mortality and could additionally reduce morbidity and disease burden. However, these advances 
against acute enteric infections now raise the relative importance of chronic intestinal 
dysfunction as a hindrance to optimal childhood health [42]. 
However, this problem is much more complex: emphasis on acute enteric infection fails 
to address the consequences of recurrent, persistent, and chronic diarrhea, as well as the long-
term consequences of diarrhea on stunting and on disability-adjusted life years. Also, a new 
variety of agents, in particular enteroaggregative Escherichia coli, and Cryptosporidia spp., 
which each require special technologies to identify, have recently and repeatedly been 
associated with persistent diarrhea and stunting. Additionally, several epidemiologic studies 
suggested that the frequency of episodes of acute diarrhea impairs long-term health in 
populations outside Brazil [18, 43, 44]. In view of the successes of oral rehydration and the 
rotavirus vaccine, it was reasonable to assume that the problem of enteric infections in children 
would be solved. Moreover, simple infrastructural management strategies, particularly the 
provision of appropriate village waste containment facilities [45] were determined to be 
important protective measures against chronic diarrhea. We now recognize that enteric 
inflammation is a determinant of stunting and long-term gastrointestinal dysfunction, even 
independent of the presence of the more easily enumerable episodes of diarrhea [45]. 
The renewed interest in EED is aptly timed for many different reasons. As noted above, 
we are in an era in which we know how to treat and prevent acute diarrhea. Therefore, chronic 
intestinal injury and inflammation now pose larger proportional threats to population and 
childhood well-being. Also, translational research has created new proteomic, metabolomic, and 
genomic technology with which to study human pathophysiology. The value of re-examining and 
expanding diagnostic capabilities is two-fold. First, such efforts will shed light on incidence rates 
within communities and assess factors associated with differences in disease rates in various 
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populations. Second, such tools might accurately identify children at risk of developing EED, 
who have EED (at its various clinical stages), and as a way to monitor treatment for EED.  
We recognize that other priorities compete with EED for resources in the field of child 
health. First, there is the imperative to continue to reduce mortality from acute diarrhea. Indeed, 
the Child Health and Nutrition Research Initiative of the Global Forum for Health Research 
methodology de-emphasized research on chronic enteric conditions in favor of implementing 
available strategies to continue to reduce acute childhood diarrhea mortality [46, 47]. That 
analysis was weighted towards interventions that could be implemented by 2015 to meet 
Millennium Development Goals. EED intervention studies require longer investigation periods 
than do disorders with known etiologies and outcomes that are apparent in the short term. For 
example, the pathophysiology of EED is not well understood, technologies sufficient to assess 
the process in individual hosts or within populations are not broadly available, and interventions 
to mitigate consequences of clinical importance are not yet established. Work to understand and 
control EED should be viewed as complementing, rather than competing with, continued efforts 
to reduce the burden of acute enteric illnesses. It was with this concept in mind that we 
embarked on our review of the EED literature, with a goal of providing a platform on which 
future EED efforts, especially those related to biomarkers and diagnostics, could be built.  
1.3 Pathophysiologic Processes and Consequences 
of EED 
The gut is an organ that is central to health and development. Healthy intestinal 
functioning optimizes childhood physical and intellectual well-being and development, and 
enables children to achieve adult stature. Several lines of evidence indicate that suboptimal 
functioning of the human gut, manifesting as EED, leads to poor health for children in resource-
poor settings. First, investigators in Fortaleza, Brazil have demonstrated that episodes of 
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recurrent or persistent diarrhea are major determinants of childhood growth impairment [48], 
and subsequent reduced growth and intellectual capacity at school entrance [49, 50]. These 
investigations were seminal because they provided a new metric for calculating the burden of 
enteric-related disease other than counting deaths or numbers of episodes of loose stools. This 
is also important because stunting can be associated with subclinical intestinal inflammation [15, 
51]. 
Multiple aspects of intestinal pathophysiology contribute to poor health, growth and 
development (Figure 2) and physiologic derangements in these processes are deleterious 
(Figure 3). First, injured intestinal mucosa absorbs nutrients poorly [52] and represents one 
potential EED-mediated growth-failure pathway [15, 53]. Chronic intestinal inflammation is very 
common in the tropics [54] and can damage intestinal epithelial integrity and disrupt tight 
junctions, resulting in intestinal permeability defects. Multiple studies demonstrate increased 
intestinal porosity in children in the tropics [15, 44, 55-58]. Increased intestinal permeability can, 
in turn, lead to translocation or the nonphysiologic uptake of intestinal luminal contents, 
including microbes and microbial products, into the bloodstream [59]. Microbial translocation 
can, in turn, mediate systemic inflammation as can chronic intestinal inflammation. Stunting is 
often associated with subclinical intestinal inflammation [15, 51]. Systemic inflammation can 
penalize growth by interrupting bone growth potential, release of growth hormone binding 
proteins at the level of the liver [60], suppressing appetite, and increasing metabolic 
requirements [61]. Such mechanistic attribution remains hypothetical at this juncture. 
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Figure 2. The vicious cycle of intestinal dysfunction, infectious disease susceptibility, 
poor growth, and development. 
NCDs= non-communicable diseases. WaSH=water, sanitation and hygiene. EED= 
environmental enteric dysfunction.  
 
Adapted from Denno DM [62], Guerrant RL, et al. [63] and Mata L [64].   
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Figure 3. EED-related pathophysiological processes result in stunting and/or growth 
shortfall. 
Growth can be affected by disturbances in a variety of intestinal and other physiologic 
processes resulting from EED. GH=growth hormone. 
 
 
The first several years of childhood represent a critical period that influences life-long 
nutritional and health status and human potential [65]. Stunting is an especially important cause 
of adverse consequences in resource-poor regions, and stunting that occurs in the first two 
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years of life is particularly consequential [48, 66-72]. Childhood stunting is associated with 
cognitive impairment, poor school performance, and reduced adult capacity [73-76]. Clinical 
complications of childhood stunting also include predisposition to obesity and diabetes and 
other chronic diseases in later adulthood—a double burden increasingly afflicting populations in 
resource-limited settings [65]. Moreover, undernutrition contributes to over one-third of 
childhood deaths [77]. 
Poor nutrition among girls can have a particularly profound effect on future reproductive 
and fetal/neonatal health. For example, maternal stunting can be a risk factor for obstructed 
labor, stillbirth, and neonatal mortality [78]. Furthermore, maternal anthropometry also 
influences future generational growth, morbidity and mortality [79].  
Dysfunctional guts can hinder the efficacy of oral vaccinations and absorption of 
medications. This may pose a threat to oral enteric vaccine strategies and absorption of 
medications for chronic infections such as tuberculosis and HIV/AIDS [80]. Indeed, failure of oral 
polio vaccine to induce protective immunity in children at risk is a major challenge to disease 
eradication [81].  
Increasing dietary nutrient provision does not necessarily or completely resolve growth 
failure in resource-poor settings [82]. Gut function is an important antecedent to healthy human 
growth and development. Strategies are needed to ascertain gut inflammation, increased 
permeability, and decreased absorption. Strategies are also needed to measure and address 
the persistence, progression, and resolution of these types of dysfunction. Chronic intestinal 
inflammation and inability to absorb nutrients may be the most actionable manifestations of 
enteric dysfunction in children. Intervention studies to mitigate EED will require appropriate, 
robust and reproducible methods to identify children with intestinal dysfunction, ideally before 
penalties to growth and development accrue.  
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A coordinated effort to control EED in children in resource-poor regions could markedly 
reduce childhood undernutrition, poor development, and mortality. In the past decade, we have 
seen an explosion in our understanding and abilities to diagnose an analogous disorder, i.e., 
celiac disease, which has histopathologic similarities to EED. We have learned the genetic and 
environmental, i.e., dietary, risk factors for celiac disease, and also determined that this disorder 
is not confined to individuals of northern European ancestry, as previously thought. 
Furthermore, the diagnosis and management of celiac disease, including partial mitigation of 
growth consequences, has advanced, at least in high-income countries. Similar data are 
emerging regarding the more challenging disorders of inflammatory bowel disease, i.e., Crohn’s 
disease and ulcerative colitis [83]. We can apply lessons learned from these chronic intestinal 
inflammatory states to the study of EED.  
There is reason to be optimistic about renewed research and development relevant to 
EED. Emerging technologies can interrogate human processes and microbial populations to an 
extent not predicted even a few years ago. These technologies can shed new light on EED, an 
entity that has traditionally required tissue for diagnosis. 
1.4 The Role of Biomarkers and Diagnostics in EED 
Much as pioneering studies on mechanisms of intestinal secretion in cholera [84] formed 
the basis for giving oral rehydration solution to children with diarrhea worldwide, it is critical to 
identify the mechanisms underlying intestinal dysfunction in children in resource-poor areas. 
Beyond searches for specific etiologic pathogens or nutritional deficiencies, biomarkers and 
diagnostics will need to be broadly considered in favor of pursuing a better understanding of 
EED as a disorder. “Discovery” efforts will be needed to generate sufficient information to move 
forward.  
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Broad-based research is urgently needed to invigorate the field. For example, multi-
dimensional assessments of individuals and populations will be necessary to measure intestinal 
dysfunction, and identify factors that precipitate and perpetuate EED. We believe that the utility 
of biomarkers in EED needs to extend beyond the concept of diagnostics. Diagnostics, as most 
commonly used to assess the human gut, usually seek specific pathogens, or belong to a 
limited panel of tests of gut inflammation and/or absorptive function. It is likely that rigorous and 
systematic analyses of EED require a better understanding of the microbial population in the gut 
and detailed assessments of intestinal inflammation, absorption, permeability, translocation, and 
subsequent systemic inflammatory cascade as well as the precipitants and consequences of 
EED, such as nutrient deficiencies. As such, we sought to systematically search, review and 
portray the existing diagnostics/biomarkers literature related to EED as a basis of knowledge to 
leverage further investigation. 
1.5 Scientific Basis for this Review 
In view of increasing understanding of the role of gut health and function in promoting 
overall health and development in childhood and beyond, it is logical to catalyze efforts to 
accurately identify and predict children with EED and to refine the sensitivity and specificity of 
promising biomarkers. While a single marker with optimal operating characteristics would be a 
welcome tool, it is unlikely that a single test can be used worldwide to detect and predict EED 
with the necessary precision. A panel of tests, perhaps in conjunction with clinical 
characteristics, may be necessary, akin to the Jones criteria used to diagnose acute rheumatic 
fever.  
Currently, there is no consensus on the best way to measure intestinal function either 
invasively or noninvasively. Additionally, there is no evidence that the entities of interest, i.e., 
intestinal inflammation and/or poor function associated with stunting, are caused by a single 
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etiology or that a common pathogenesis underlies all cases. Also, we do not know if intestinal 
inflammation precedes growth failure, if the disorder might actually begin in utero, or if any 
therapies can reliably and uniformly restore linear growth. Nonetheless, there is now consensus 
that stunted children are not only at risk for unhealthy consequences during childhood, they are 
more likely than their non-stunted peers to develop chronic disorders that extend into adulthood, 
including obesity, type II diabetes, and hypertension [85, 86]. Clearly there is a need to reassess 
whether existing markers of intestinal dysfunction can better define the disorder of interest, and 
anticipate its development in children. We therefore attempted to first identify the current state of 
the knowledge, then delineate gaps in that knowledge, and, finally, sought to determine which 
tests might have the most utility. 
Table 1. Spectrum of etiologies, outcomes, and biomarkers/diagnostics in EED. 
These lists of causes, results, and techniques to identify EED were used to define manuscripts 
of potential interest in the list generated by the search terms. 
Potential drivers (causes) of EED Pathogens, food insecurity, immune activation, specific 
nutrient deficiencies, environmental hygiene 
Potential consequences of EED Recurrent diarrhea, persistent diarrhea, intestinal 
inflammation with and without diarrhea, stunting 
Possible biomarkers/diagnostics of 
EED 
Biopsies, sugar clearance tests (measuring absorption 
and permeability of the gut), breath hydrogen tests, 
nutrient challenge tests, fecal analyses for leakage or 
non-absorption, serologic analyses for inflammation or 
evidence of gut permeability 
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